OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26/07/2025
Voltar para busca
Dado oficial do USPTO
HANALL BIOPHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 42
Data de depósito
16/11/2023
Data de registro
24/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/12/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
KR
Examinador
JOHNSON, AISHA CLARKE
Unidade examinadora
L10
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized wording HANALL BIOPHARMA in black, above the wording are three abstract designs of chromosomes in the colors green, yellow, and blue.
Titulares e representantes
Titulares
Hanall Biopharma Co., Ltd.
Representantes
John M. Kim IPLA, LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Reagents for use in diagnostic testing of Hepatitis B surface antibody for medical purposes and pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; tonicsmedicines for autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; anthelmintics; antiemetics; local anaesthetics; anti-cough drops; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; veterinary preparations for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; prescription synthetic narcotics; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for immunity improvement; pharmaceutical agents for treating physically caused lesions; pharmaceuticals for the treatment of erectile dysfunction; vesicants for wart removal; vaccines; adrenal hormone preparations; pharmaceutical preparations for the treatment of urogenital organs; vitamin preparations; pharmaceutical products for the treatment of bone diseases; crude medicines for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; biological preparations for veterinary purposes for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; chemical preparations for veterinary purposes for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; cardiovascular pharmaceutical preparations; chemico-pharmaceutical preparations for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; pharmaceutical agents for epidermis; medicines for the treatment of gastrointestinal diseases; diagnostic preparations for medical or veterinary purposes; drugs for medical purposes for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; medical diagnostic reagents; diuretics; medicines for human purposes for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; antacids; haematogen; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations acting on the central nervous system; analgesics; medical preparations for slimming purposes; medicines for dental purposes; dermatological pharmaceutical products; antibiotics; anti-cancer preparations; blood solvents for medical or veterinary purposes; pharmaceutical preparations for the treatment of respiratory organs; preparations for the treatment of burns; chemotherapeutics
Classe 35
Price comparison services; distribution of samples; wholesale store services featuring nutraceuticals for use as a dietary supplement; retail store services featuring nutraceuticals for use as a dietary supplement; wholesale store services featuring medical apparatus; retail store services featuring medical apparatus; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring medicines for human purposes; retail store services featuring medicines for human purposes; wholesale store services featuring fruit-based dietary supplements via the internet; retail store services featuring fruit-based dietary supplements via the internet; wholesale store services featuring make-up preparations via the internet; retail store services featuring make-up preparations via the internet; wholesale store services featuring nutraceuticals via the internet; retail store services featuring nutraceuticals via the internet; wholesale store services featuring make-up preparations; retail store services featuring make-up preparations
Classe 42
Advice in the field of construction drafting; engineering surveying; rental of scientific equipment; research relating to mechanical engineering; meteorological observation for others; services for assessing the safety of agricultural chemicals; cosmetology research services; industrial design; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research services; scientific research services in the fields of medicinehealth and pharmacology; medical research; product safety testing; textile design; research in the field of computer software development; marineaerial and land surveying; oceanography research; chemical analysis; scientific research in the nature of providing environmental impact surveys
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/07/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/07/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/06/2025
FIMP
FINAL DISPOSITION PROCESSED
14/06/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
24/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/10/2024
PUBO
PUBLISHED FOR OPPOSITION
22/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2024
RFNT
REFUSAL PROCESSED BY IB
04/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/07/2024
RFRR
REFUSAL PROCESSED BY MPU
16/07/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/06/2024
CNRT
NON-FINAL ACTION WRITTEN
24/06/2024
DOCK
ASSIGNED TO EXAMINER
21/06/2024
MAFR
APPLICATION FILING RECEIPT MAILED
16/02/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/02/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HANALL BIOPHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.